Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

17.00
+0.59003.60%
Volume:352.05K
Turnover:5.99M
Market Cap:6.02B
PE:-19.69
High:17.13
Open:16.48
Low:16.48
Close:16.41
52wk High:17.86
52wk Low:10.45
Shares:354.19M
Float Shares:42.05M
Volume Ratio:1.06
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8635
EPS(LYR):-0.9011
ROE:-4.50%
ROA:0.53%
PB:0.94
PE(LYR):-18.87

Loading ...

Company Profile

Company Name:
Bausch + Lomb Corp.
Exchange:
NYSE
Establishment Date:
1853
Employees:
13500
Office Location:
520 Applewood Crescent,Vaughan,Ontario,Canada
Zip Code:
L4K 4B4
Fax:
- -
Introduction:
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Directors

Name
Position
Brenton L. Saunders
Chief Executive Officer and Chairman of the Board
Andrew C. von Eschenbach
Independent Director
Eduardo C. Alfonso
Independent Director
John A. Paulson
Independent Director
Karen L. Ling
Independent Director
Nathalie Bernier
Independent Director
Russel C. Robertson
Independent Director
Sarah B. Kavanagh
Independent Director
Steven H. Collis
Independent Director
Thomas W. Ross, Sr.
Independent Director

Shareholders

Name
Position
Brenton L. Saunders
Chief Executive Officer and Chairman of the Board
Frederick J. Munsch
Senior Vice President, Controller and Chief Accounting Officer
Sam A. Eldessouky
Chief Financial Officer and Executive Vice President
A. Robert D. Bailey
Executive Vice President and Chief Legal Officer
Andrew J. Stewart
President, Global Pharmaceuticals and International Consumer
Luc Bonnefoy
President, Surgical
Yehia Hashad
Executive Vice President, Research and Development and Chief Medical Officer